UK to donate 100 million surplus COVID-19 vaccines to the world
London [UK], Jun 11 (ANI): The UK will donate 100 million excess doses of coronavirus vaccine to the world over the next year, UK Prime Minister Boris Johnson announced on Friday.
This commitment precedes the G7 summit, which begins Friday in Cornwall. Last week, Prime Minister Johson asked his fellow G7 leaders to help immunize the whole world by the end of next year.
“Due to the success of the UK vaccination program, we are now able to share some of our excess doses with those who need them,” Johnson said on Friday, according to excerpts from the announcement released by his office.
It comes amid growing calls for the United States and other wealthy countries to play a bigger role in increasing the global supply of coronavirus vaccines.
The UK’s announcement comes hours after US President Joe Biden pledged half a billion doses of Pfizer vaccine to 92 low- and middle-income countries and the African Union.
At the summit, world leaders are expected to announce that they will provide at least 1 billion doses of the coronavirus vaccine to the world through dose sharing and funding and will establish a plan to expand vaccine manufacturing to achieve this goal. .
The UK will donate 5 million doses by the end of September, starting in the coming weeks, mostly for use in the world’s poorest countries.
The Prime Minister also pledged to donate 95 million more doses over the next year, with 25 million more by the end of 2021. 80% of the 100 million doses will go to COVAX and the remainder will be shared bilaterally with countries in need.
By sharing 5 million doses in the coming weeks, the UK will meet the immediate demand for vaccines for countries worst affected by the coronavirus without delaying the completion of our initial national vaccination program.
The doses the UK has announced it will give today will be taken from the expected oversupply in the UK.
The 100 million figure was calculated based on the total needed to vaccinate the UK population, taking into account the possibility of detection of future vaccine resistant strains and potential disruption to our supply. (ANI)